13F-HR filed by Endurant Capital Management LP
Endurant Capital Management LP filed this 13F-HR for the quarter ended 2022-09-30, filed 2022-11-14, with 49 holding rows worth $307,049,000.
- Accession
- 0001633055-22-000007
- Filer
- CIK 1633055
- Filed
- 2022-11-14
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q3 2022
A holdings report, 49 entries on the cover page, a total value of $307,049,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $307,049,000 with VALUE read as thousands by filing date, 13F file number 028-16634. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| INVACARE CORP | 461203AJ0 | NOTE 5.000%11/1 | 56,727,000 | $49,063,000 | thousands by filing date | |
| LABORATORY CORP OF AMERICA | 50540R409 | COM NEW | 97,245 | $19,917,000 | thousands by filing date | |
| HUMANA INC COM | 444859102 | Stock | 32,729 | $15,880,000 | thousands by filing date | |
| TAKEDA PHARMACEUTICAL CO LTD SPONSORED ADS | 874060205 | ADR | 1,102,280 | $14,297,000 | thousands by filing date | |
| BAXTER INTL INC | 071813109 | COM | 245,093 | $13,201,000 | thousands by filing date | |
| QIAGEN NV | N72482123 | SHS NEW | 303,928 | $12,546,000 | thousands by filing date | |
| Eli Lilly and Company | 532457108 | COM | 38,311 | $12,388,000 | thousands by filing date | |
| BIOMARIN PHARMACEUTICAL INC | 09061G101 | COM | 145,374 | $12,323,000 | thousands by filing date | |
| ICON PUB LTD CO SHS | G4705A100 | Stock | 66,437 | $12,210,000 | thousands by filing date | |
| Bristol-Myers Squibb Company | 110122108 | COM | 158,721 | $11,283,000 | thousands by filing date | |
| CATALENT INC USD 0.01 | 148806102 | COM | 140,077 | $10,136,000 | thousands by filing date | |
| Cigna Corporation | 125523100 | COM | 34,099 | $9,461,000 | thousands by filing date | |
| OMEGA HEALTHCARE INVS INC COM | 681936100 | REIT | 313,762 | $9,253,000 | thousands by filing date | |
| INVACARE CORP | 461203AL5 | NOTE 5.000%11/1 | 10,097,000 | $8,438,000 | thousands by filing date | |
| ELUTIA INC | 05479K106 | CL A COM | 1,139,932 | $8,208,000 | thousands by filing date | |
| BECTON DICKINSON & CO | 075887109 | COM | 34,282 | $7,639,000 | thousands by filing date | |
| Elevance Health, Inc. | 036752103 | COM | 16,402 | $7,450,000 | thousands by filing date | |
| ZOETIS INC CL A | 98978V103 | Stock | 44,286 | $6,567,000 | thousands by filing date | |
| SELECTA BIOSCIENCES INC | 816212104 | COM | 3,938,409 | $6,459,000 | thousands by filing date | |
| ASTRAZENECA PLC SPONSORED ADR | 046353108 | ADR | 101,048 | $5,541,000 | thousands by filing date | |
| MCKESSON CORP COM | 58155Q103 | Stock | 16,168 | $5,495,000 | thousands by filing date | |
| OCULAR THERAPEUTIX INC | 67576A100 | COM | 1,064,295 | $4,417,000 | thousands by filing date | |
| ENCOMPASS HEALTH CORP COM | 29261A100 | Stock | 82,929 | $3,751,000 | thousands by filing date | |
| TENET HEALTHCARE CORP COM NEW | 88033G407 | Stock | 70,535 | $3,638,000 | thousands by filing date | |
| VENTAS INC COM | 92276F100 | REIT | 85,683 | $3,442,000 | thousands by filing date | |
| ALBIREO PHARMA INC | 01345P106 | COMMON STOCK | 172,621 | $3,342,000 | thousands by filing date | |
| BIO RAD LABS INC | 090572207 | CL A | 6,984 | $2,913,000 | thousands by filing date | |
| MERIT MED SYS INC COM | 589889104 | Stock | 51,218 | $2,894,000 | thousands by filing date | |
| ARCUS BIOSCIENCES INC | 03969F109 | COM | 97,327 | $2,546,000 | thousands by filing date | |
| INSMED INC COM PAR $.01 | 457669307 | Stock | 107,713 | $2,320,000 | thousands by filing date | |
| LAKEFRONT BIOTHERAPEUTICS NV | 36315X101 | SPON ADR | 50,822 | $2,167,000 | thousands by filing date | |
| ADAPTIMMUNE THERAPEUTICS PLC | 00653A107 | SPONDS ADR | 1,788,517 | $1,923,000 | thousands by filing date | |
| CANO HEALTH INC | 13781Y103 | COM | 210,915 | $1,829,000 | thousands by filing date | |
| VERACYTE INC COM | 92337F107 | Stock | 108,751 | $1,805,000 | thousands by filing date | |
| AVANTOR INC COM | 05352A100 | Stock | 75,948 | $1,489,000 | thousands by filing date | |
| SUTRO BIOPHARMA INC | 869367102 | COM | 266,679 | $1,480,000 | thousands by filing date | |
| TEVA PHARMACEUTICAL INDS LTD SPONSORED ADS | 881624209 | ADR | 179,226 | $1,446,000 | thousands by filing date | |
| OPTION CARE HEALTH INC COM NEW | 68404L201 | Stock | 43,457 | $1,368,000 | thousands by filing date | |
| ACCENDRA HEALTH INC | 690732102 | COM | 55,914 | $1,348,000 | thousands by filing date | |
| VAXCYTE INC COM | 92243G108 | Stock | 52,309 | $1,255,000 | thousands by filing date | |
| REATA PHARMACEUTICALS INC | 75615P103 | CL A | 24,352 | $612,000 | thousands by filing date | |
| MARAVAI LIFESCIENCES HLDGS A | 56600D107 | COMMON STOCK | 22,709 | $580,000 | thousands by filing date | |
| ACUMEN PHARMACEUTICALS INC | 00509G209 | CMN | 55,328 | $555,000 | thousands by filing date | |
| MIRATI THERAPEUTICS INC | 60468T105 | COM | 7,915 | $553,000 | thousands by filing date | |
| RELMADA THERAPEUTICS INC | 75955J402 | COMMON STOCK | 14,145 | $524,000 | thousands by filing date | |
| CYTOKINETICS INC | 23282W605 | COM NEW | 9,211 | $446,000 | thousands by filing date | |
| MORPHOSYS AG | 617760202 | ADR | 68,290 | $344,000 | thousands by filing date | |
| BIODESIX INC | 09075X108 | COM | 130,136 | $165,000 | thousands by filing date | |
| ATHENEX INC | 04685N103 | COM | 526,651 | $142,000 | thousands by filing date |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001633055-22-000007 | this filing | 2022-11-14 | acceptance time not in the bulk data set |